Description
Recombinant monoclonal antibody to RANK-L. Manufactured using AbAbТs Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 14F3. This is a reformatted human IgG1 Fc SilentЩ antibody, based on the original human IgG2a format, created for improved compatibility with existing reagents, assays and techniques.
Target
RANK-L
Target Alias Names
CD254, TRANCE, RANKL, ODF, OPGL, Tumor necrosis factor ligand superfamily member 11, Osteoclast differentiation factor, Osteoprotegerin ligand, Receptor activator of nuclear factor kappa-B ligand, TNF-related activation-induced cytokine
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression